Shop

PRODUCTS


LEVOSTAT

2,000.00

LEVOSTAT is indicated for the treatment of mild, moderate and severe infections caused by susceptible strains of the designated micro-organisms

Product Description

LEVOSTAT® is indicated for the treatment of mild, moderate and severe infections caused by susceptible strains of the designated micro-organisms in the condition listed below:

* Genito – Urinary Tract infections (Complicated and non-complicated).

* Skin and Skin Structure infection.

* Sinusitis

* Community Acquired Pneumonia

* Intra-Abdominal Infection

* Bronchitis

Levofloxacin acts on DNA-DNA gyrase complex by inhibiting DNA GYRASE (bacterial topoisomerase II), an enzyme required for DNA replication, transcription, repair and combination and topoisomerase IV.

Pharmacology:

Orally administered LEVOSTAT® is rapidly and almost completely absorbed with the peak plasma concentration being obtained within one hour. The absolute bioavailability is approximately 100%.


    Reviews

    There are no reviews yet.

    Be the first to review “LEVOSTAT”

    sterling-removebg-preview

    Sterling BioPharma Limited is a indigenous pharmaceutical company that develop, produce, market and distribute a high quality range of pharmaceutical products.

    Recent Posts

    Products

    Copyright by Sterling BioPharma Limited. All rights reserved.

    Open chat